Quick Answer
NP Life Sciences Health Industry Group Inc. reported Total Revenue of $164.6 thousand for fiscal year 2023.
NP Life Sciences Health Industry Group Inc. — Key Financials by Year
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Total Revenue | $164.6K +61.4% |
$102.0K +191.5% |
$35.0K +133.3% |
$15.0K -65.1% |
$43.0K | — |
| Revenue (ASC 606) | $164.6K +61.4% |
$102.0K +191.5% |
$35.0K +133.3% |
$15.0K -65.1% |
$43.0K | — |
| Net Income | -$2.9K +84.4% |
-$18.9K +71.3% |
-$65.7K +49.9% |
-$131.1K -20.4% |
-$108.8K -421.1% |
-$20.9K |
| Diluted EPS | $0.00 | $0.00 | — | — | — | — |
| Total Assets | $76.9K -39.8% |
$127.8K +232.7% |
$38.4K -67.6% |
$118.6K -52.6% |
$250.1K +124948.5% |
$200.00 |
| Cash and Equivalents | $70.6K -42.1% |
$121.9K +335.4% |
$28.0K -76.4% |
$118.6K -51.2% |
$242.9K +121366.5% |
$200.00 |
| Stockholders Equity | $16.4K -15.2% |
$19.3K -49.4% |
$38.2K -63.2% |
$103.8K -55.8% |
$234.9K +1235.7% |
-$20.7K |
| Operating Income | -$690.00 +96.3% |
-$18.9K +71.3% |
-$65.7K +49.9% |
-$131.1K -20.4% |
-$108.9K -421.2% |
-$20.9K |
| Shares Outstanding | 42.96M +0.0% |
42.96M +0.0% |
42.96M +0.0% |
42.96M +0.0% |
42.96M +64340.0% |
66,666 |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2023 | $17.5K | -57.3% | -83.6% |
| Revenue (ASC 606) | September 30, 2023 | $17.5K | -57.3% | -83.6% |
| Net Income | September 30, 2023 | -$37.7K | -592.5% | -152.9% |
| Total Assets | September 30, 2023 | $95.3K | +462.6% | -33.9% |
| Cash and Equivalents | September 30, 2023 | $84.6K | +1116.4% | -32.4% |
| Stockholders Equity | September 30, 2023 | $31.7K | +1067.6% | -52.7% |
| Operating Income | September 30, 2023 | -$37.4K | -588.3% | -152.4% |
| Shares Outstanding | September 30, 2023 | 42.96M | +0.0% | +0.0% |
- NP Life Sciences Health Industry Group Inc. reported Total Revenue of $164.6 thousand for fiscal year 2023.
- NP Life Sciences Health Industry Group Inc. showed an increase of +61.4% in Total Revenue compared to the prior fiscal year.
- NP Life Sciences Health Industry Group Inc. reported Revenue (ASC 606) of $164.6 thousand for fiscal year 2023.
- NP Life Sciences Health Industry Group Inc. showed an increase of +61.4% in Revenue (ASC 606) compared to the prior fiscal year.
- NP Life Sciences Health Industry Group Inc. reported Net Income of -$2.9 thousand for fiscal year 2023.
- NP Life Sciences Health Industry Group Inc. showed an increase of +84.4% in Net Income compared to the prior fiscal year.
- NP Life Sciences Health Industry Group Inc. reported Diluted EPS of $0.00 per share for fiscal year 2023.
- NP Life Sciences Health Industry Group Inc. reported Total Assets of $76.9 thousand for fiscal year 2023.
- NP Life Sciences Health Industry Group Inc. showed a decrease of -39.8% in Total Assets compared to the prior fiscal year.
- NP Life Sciences Health Industry Group Inc. reported Cash and Equivalents of $70.6 thousand for fiscal year 2023.
- NP Life Sciences Health Industry Group Inc. showed a decrease of -42.1% in Cash and Equivalents compared to the prior fiscal year.
- NP Life Sciences Health Industry Group Inc. reported Stockholders Equity of $16.4 thousand for fiscal year 2023.
- NP Life Sciences Health Industry Group Inc. showed a decrease of -15.2% in Stockholders Equity compared to the prior fiscal year.
- NP Life Sciences Health Industry Group Inc. reported Operating Income of -$690.00 for fiscal year 2023.
- NP Life Sciences Health Industry Group Inc. showed an increase of +96.3% in Operating Income compared to the prior fiscal year.
- NP Life Sciences Health Industry Group Inc. reported Shares Outstanding of 42.96 million shares for fiscal year 2023.
- NP Life Sciences Health Industry Group Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: